abstract |
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the modulation of the GPR40 receptor. Such compounds are represented by Formula (I) as follows: n nwherein U 1 , U 2 , U 3 , R 1 , R 2 , Z, and W are defined herein. |